Fayez M. Hamzeh

Chemotherapy for Human Immunodeficiency Virus–Associated Non-Hodgkin’s Lymphoma in Combination With Highly Active Antiretroviral Therapy

Lee Ratner, Jeannette Y. Lee, Shenghui Tang et al. · Journal of Clinical Oncology · 2001 · 278 citations

Impact of Ribavirin Dose Reductions in Hepatitis C Virus Genotype 1 Patients Completing Peginterferon Alfa-2a/Ribavirin Treatment

K. Rajender Reddy, Mitchell L. Shiffman, Timothy R. Morgan et al. · Clinical Gastroenterology and Hepatology · 2006 · 193 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +8

Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C

M. Rodríguez‐Torres, Lennox J. Jeffers, Muhammad Y. Sheikh et al. · New England Journal of Medicine · 2009 · 182 citations

Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection

Stuart C. Gordon, Paul J. Pockros, Norah A. Terrault et al. · Hepatology · 2012 · 112 citations · Full text

Synthesis of 9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): A potential imaging agent of viral infection and gene therapy using PET

Mian M. Alauddin, Peter S. Conti, Samuel M. Mazza et al. · Nuclear Medicine and Biology · 1996 · 103 citations · Full text

Bioorganic Chemistry, Engineering, Imaging Agent +18